CD4+ T lymphocytes can inhibit tumour growth via immune surveillance, whereas CD8+ T cells are highly enriched in the MASLD microenvironment, contributing to liver inflammation [8, 9, 10]. The gene discussed is CD8A; the disease is neoplasm.